Polycystic ovary syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Oligomenorrhea or lack of ovlation polycystic ovaries based on ultrasound Androgenic hormone changes in laboratory or clinical form (the presence of hirsutism)
Exclusion criteria
Exclusion criteria: Type 2 diabets Thyroid disease Adernal hyperplasia Autoimmune disease Hyperprolactinemia People with structured physical activity or scheduled exercise If three months before entering the study,they use a special diet or special drugs that may affect the results ,they will be excluded from the study ,such as anti-obesity drugs,induction ovulation,antidepressants,insulin sensivity,oral contraceotives,asprin,and anti-prostaglandin drugs If there are signs of pregnancy,they will be excludedfrom the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Malondialdehyde(MDA). Timepoint: Before and after 12 weeks of intervention. Method of measurement: Determination of serum level.;Total antioxidant capacity(TAOC). Timepoint: Before and after 12 weeks of intervention. Method of measurement: Determination of serum level. | — |
Secondary
| Measure | Time frame |
|---|---|
| Triglyceride. Timepoint: Before and after 12 weeks of intervention. Method of measurement: Determination of serum level.;Cholesterol. Timepoint: Before and after 12 weeks of intervention. Method of measurement: Determination of serum level.;High-density lipoprotein (HDL). Timepoint: Before and after 12 weeks of intervention. Method of measurement: Determination of serum level.;Low-density lipoprotein (LDL). Timepoint: Before and after 12 weeks of intervention. Method of measurement: Determination of serum level. | — |
Countries
Iran (Islamic Republic of)
Contacts
Ardabil University of Medical Sciences